Sign in to view content

Platform for Screening Compounds for Treatment of AMD Using iPSC-derived human RPE: Examples Using Elamipretide and SBT-272

Lucian V. Del Priore, MD, PhD

Video
Published 2022

Related

Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study
W. Lloyd Clark, MD, FASRS
Updates from the Field
2022
Baseline Characteristics in the Phase 2 GOLDEN Study of IONIS-FB-LRx, an Investigational Antisense Oligonucleotide Designed to Treat AMD-Associated Geographic Atrophy
Glenn J. Jaffe, MD
Annual Meeting Talks
2022
Quality of Life and Retinal Disease During the COVID-19 Pandemic
Peter Y Zhao, MD
Annual Meeting Talks
2021

Category: AMD-Non-Neovascular

See more